Positive Role of Promyelocytic Leukemia Protein in Type I Interferon Response and Its Regulation by Human Cytomegalovirus

PLoS Pathogens

Volumn 11, Issue 3, 2015, Pages 1-24

  Kim, Young Eui ^a   Ahn, Jin Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; IE1 PROTEIN; INTERFERON; INTERFERON STIMULATED GENE FACTOR 3; PEPTIDES AND PROTEINS; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN ISG54; STAT1 PROTEIN; STAT2 PROTEIN; UNCLASSIFIED DRUG; HDAC1 PROTEIN, HUMAN; HDAC2 PROTEIN, HUMAN; IE1 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN; INTERFERON REGULATORY FACTOR 9; IRF9 PROTEIN, HUMAN; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; STAT1 PROTEIN, HUMAN; STAT2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BINDING KINETICS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOMEGALOVIRUS INFECTION; DNA TRANSFECTION; ELECTROPORATION; FIBROBLAST; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREGULATION; MUTANT; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; CYTOMEGALOVIRUS; GENETICS; HEK293 CELL LINE; METABOLISM;

HUMAN HERPESVIRUS 5;

CYTOMEGALOVIRUS; HEK293 CELLS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERFERON TYPE I; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; NUCLEAR PROTEINS; PROMYELOCYTIC LEUKEMIA PROTEIN; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84926433175     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004785     Document Type: Article

References (61)

1. Samuel CE, Antiviral actions of interferons. Clin Microbiol Rev. 2001;14(4):778–809. 11585785
2. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, et al. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature. 1996;383(6598):344–7. 8848048
3. Paulson M, Press C, Smith E, Tanese N, Levy DE, IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat Cell Biol. 2002;4(2):140–7. 11802163
4. Nusinzon I, Horvath CM, Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci U S A. 2003;100(25):14742–7. 14645718
5. Chang HM, Paulson M, Holko M, Rice CM, Williams BR, Marie I, et al. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci U S A. 2004;101(26):9578–83. 15210966
6. Sakamoto S, Potla R, Larner AC, Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. J Biol Chem. 2004;279(39):40362–7. 15194680
7. Nusinzon I, Horvath CM, Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. Mol Cell Biol. 2006;26(8):3106–13. 16581785
8. Huang M, Qian F, Hu Y, Ang C, Li Z, Wen Z, Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes. Nature cell biology. 2002;4(10):774–81. 12244326
9. Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K, et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. Embo J. 1995;14(7):1532–41. 7729428
10. Jensen K, Shiels C, Freemont PS, PML protein isoforms and the RBCC/TRIM motif. Oncogene. 2001;20(49):7223–33. 11704850
11. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 1999;147(2):221–34. 10525530
12. Bernardi R, Pandolfi PP, Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol. 2007;8(12):1006–16. 17928811
13. Krieghoff-Henning E, Hofmann TG, Role of nuclear bodies in apoptosis signalling. Biochimica et biophysica acta. 2008;1783(11):2185–94. doi: 10.1016/j.bbamcr.2008.07.002 18680765
14. Gamell C, Jan Paul P, Haupt Y, Haupt S, PML tumour suppression and beyond: therapeutic implications. FEBS letters. 2014;588(16):2653–62. doi: 10.1016/j.febslet.2014.02.007 24548562
15. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venturini L, Stadler M, et al. Induction of the PML protein by interferons in normal and APL cells. Leukemia. 1995;9(12):2027–33. 8609713
16. Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, Lebon P, et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene. 1995;11(5):871–6. 7545807
17. Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A, et al. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene. 1992;7(6):1083–91. 1594241
18. Everett RD, Chelbi-Alix MK, PML and PML nuclear bodies: implications in antiviral defence. Biochimie. 2007;89(6–7):819–30. 17881113
19. Tavalai N, Stamminger T, New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta. 2008;1783(11):2207–21. doi: 10.1016/j.bbamcr.2008.08.004 18775455
20. Schreiner S, Wodrich H, Virion factors that target Daxx to overcome intrinsic immunity. J Virol. 2013;87(19):10412–22. doi: 10.1128/JVI.00425-13 23864634
21. Geoffroy MC, Chelbi-Alix MK, Role of promyelocytic leukemia protein in host antiviral defense. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2011;31(1):145–58.
22. Boutell C, Cuchet-Lourenco D, Vanni E, Orr A, Glass M, McFarlane S, et al. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS pathogens. 2011;7(9):e1002245. doi: 10.1371/journal.ppat.1002245 21949651
23. Ahn JH, Hayward GS, The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol. 1997;71(6):4599–613. 9151854
24. Ahn JH, Brignole EJ, 3rdHayward GS, Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol. 1998;18(8):4899–913. 9671498
25. Wilkinson GW, Kelly C, Sinclair JH, Rickards C, Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J Gen Virol. 1998;79 (Pt 5):1233–45. 9603339
26. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J, The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res. 1996;229(1):155–8. 8940259
27. Ahn JH, Hayward GS, Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology. 2000;274(1):39–55. 10936087
28. Lee HR, Kim DJ, Lee JM, Choi CY, Ahn BY, Hayward GS, et al. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol. 2004;78(12):6527–42. 15163746
29. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T, Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol. 2006;80(16):8006–18. 16873257
30. Tavalai N, Papior P, Rechter S, Stamminger T, Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol. 2008;82(1):126–37. 17942542
31. Lee HR, Huh YH, Kim YE, Lee K, Kim S, Ahn JH, N-terminal determinants of human cytomegalovirus IE1 protein in nuclear targeting and disrupting PML-associated subnuclear structures. Biochem Biophys Res Commun. 2007;356(2):499–504. 17367754
32. Paulus C, Krauss S, Nevels M, A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A. 2006;103(10):3840–5. 16497831
33. Huh YH, Kim YE, Kim ET, Park JJ, Song MJ, Zhu H, et al. Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol. 2008;82(21):10444–54. doi: 10.1128/JVI.00833-08 18701593
34. Krauss S, Kaps J, Czech N, Paulus C, Nevels M, Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2. J Virol. 2009;83(24):12854–70. doi: 10.1128/JVI.01164-09 19812155
35. Shin HJ, Kim YE, Kim ET, Ahn JH, The chromatin-tethering domain of human cytomegalovirus immediate-early (IE) 1 mediates associations of IE1, PML and STAT2 with mitotic chromosomes, but is not essential for viral replication. J Gen Virol. 2012;93(Pt 4):716–21. doi: 10.1099/vir.0.037986-0 22158879
36. Scherer M, Klingl S, Sevvana M, Otto V, Schilling EM, Stump JD, et al. Crystal structure of cytomegalovirus IE1 protein reveals targeting of TRIM family member PML via coiled-coil interactions. PLoS Pathog. 2014;10(11):e1004512. doi: 10.1371/journal.ppat.1004512 25412268
37. Nevels M, Paulus C, Shenk T, Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc Natl Acad Sci U S A. 2004;101(49):17234–9. 15572445
38. El Bougrini J, Dianoux L, Chelbi-Alix MK, PML positively regulates interferon gamma signaling. Biochimie. 2011;93(3):389–98. doi: 10.1016/j.biochi.2010.11.005 21115099
39. Ulbricht T, Alzrigat M, Horch A, Reuter N, von Mikecz A, Steimle V, et al. PML promotes MHC class II gene expression by stabilizing the class II transactivator. The Journal of cell biology. 2012;199(1):49–63. doi: 10.1083/jcb.201112015 23007646
40. El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK, Implication of PMLIV in both intrinsic and innate immunity. PLoS pathogens. 2014;10(2):e1003975. doi: 10.1371/journal.ppat.1003975 24586174
41. Yu Y, Maguire TG, Alwine JC, ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells. Proc Natl Acad Sci U S A. 2014;111(5):1951–6. doi: 10.1073/pnas.1310779111 24449882
42. Meng Z, Zhang X, Wu J, Pei R, Xu Y, Yang D, et al. RNAi induces innate immunity through multiple cellular signaling pathways. PLoS One. 2013;8(5):e64708. doi: 10.1371/journal.pone.0064708 23700487
43. Wu WS, Vallian S, Seto E, Yang WM, Edmondson D, Roth S, et al. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol. 2001;21(7):2259–68. 11259576
44. Greaves RF, Mocarski ES, Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol. 1998;72(1):366–79. 9420235
45. Chen X, Barozzi I, Termanini A, Prosperini E, Recchiuti A, Dalli J, et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci U S A. 2012;109(42):E2865–74. doi: 10.1073/pnas.1121131109 22802645
46. Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Wetzel JL, Sen GC, Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivators. mBio. 2013;4(2). pii: e00636–12. doi: 10.1128/mBio.00636-12 23532979
47. Zhu J, Coyne CB, Sarkar SN, PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and beta-catenin. EMBO J. 2011;30(23):4838–49. doi: 10.1038/emboj.2011.351 21952047
48. Zheng P, Guo Y, Niu Q, Levy DE, Dyck JA, Lu S, et al. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature. 1998;396(6709):373–6. 9845074
49. Bruno S, Ghiotto F, Fais F, Fagioli M, Luzi L, Pelicci PG, et al. The PML gene is not involved in the regulation of MHC class I expression in human cell lines. Blood. 2003;101(9):3514–9. 12506025
50. Amalraj J, Cutler SJ, Ghazawi I, Boyle GM, Ralph SJ, REST negatively and ISGF3 positively regulate the human STAT1 gene in melanoma. Mol Cancer Ther. 2013;12(7):1288–98. doi: 10.1158/1535-7163.MCT-12-0923 23598529
51. Andres ME, Burger C, Peral-Rubio MJ, Battaglioli E, Anderson ME, Grimes J, et al. CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Natl Acad Sci U S A. 1999;96(17):9873–8. 10449787
52. Huang Y, Myers SJ, Dingledine R, Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nature neuroscience. 1999;2(10):867–72. 10491605
53. Choi YH, Bernardi R, Pandolfi PP, Benveniste EN, The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling. Proc Natl Acad Sci U S A. 2006;103(49):18715–20. 17121994
54. Mounce BC, Mboko WP, Kanack AJ, Tarakanova VL, Primary macrophages rely on histone deacetylase 1 and 2 expression to induce type I interferon in response to gammaherpesvirus infection. J Virol. 2014;88(4):2268–78. doi: 10.1128/JVI.03278-13 24335310
55. Yu SS, Kim JM, Kim S, High efficiency retroviral vectors that contain no viral coding sequences. Gene Ther. 2000;7(9):797–804. 10822307
56. Roth MB, Zahler AM, Stolk JA, A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J Cell Biol. 1991;115(3):587–96. 1717489
57. Park JJ, Kim YE, Pham HT, Kim ET, Chung YH, Ahn JH, Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts. J Gen Virol. 2007;88(Pt 12):3214–23. 18024889
58. Kim YE, Lee JH, Kim ET, Shin HJ, Gu SY, Seol HS, et al. Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol. 2011;85(22):11928–37. doi: 10.1128/JVI.00758-11 21880768
59. Cheng X, Kao HY, Microarray analysis revealing common and distinct functions of promyelocytic leukemia protein (PML) and tumor necrosis factor alpha (TNFalpha) signaling in endothelial cells. BMC Genomics. 2012;13:453. doi: 10.1186/1471-2164-13-453 22947142
60. Kim ET, Kim YE, Kim YJ, Lee MK, Hayward GS, Ahn JH, Analysis of Human Cytomegalovirus-enoded SUMO trgets and temporal regulation of SUMOylation of the immediate-early proteins IE1 and IE2 during infection. PLoS One. 2014;9(7):e103308. doi: 10.1371/journal.pone.0103308 25050850
61. Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, de Jong L, et al. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci. 1992;101 (Pt 4):773–84. 1527179